CTRE:NYE-CareTrust REIT Inc. (USD)

COMMON STOCK | REIT - Healthcare Facilities |

Last Closing

USD 27.39

Change

+0.17 (+0.62)%

Market Cap

USD 5.50B

Volume

0.54M

Analyst Target

USD 18.67
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

CareTrust REIT, Inc.'s ("CareTrust REIT" or the "Company") primary business consists of acquiring, financing, developing and owning real property to be leased to third-party tenants in the healthcare sector. As of March 31, 2024, the Company owned directly or through a joint venture and leased to independent operators, 228 skilled nursing facilities ("SNFs"), multi-service campuses, assisted living facilities ("ALFs") and independent living facilities ("ILFs") consisting of 24,189 operational beds and units located in 29 states with the highest concentration of properties by rental income located in California and Texas. As of March 31, 2024, the Company also had other real estate related investments consisting of one preferred equity investment, nine real estate secured loans receivable and four mezzanine loans receivable with a carrying value of $233.3 million.

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-12-24 )

Largest Industry Peers for REIT - Healthcare Facilities

Symbol Name Price(Change) Market Cap
WELL Welltower Inc

+0.97 (+0.77%)

USD 77.61B
VTR Ventas Inc

+0.34 (+0.58%)

USD 24.65B
DOC Healthpeak Properties Inc

+0.21 (+1.04%)

USD 14.07B
AHR American Healthcare REIT, Inc.

+0.42 (+1.49%)

USD 4.56B
NHI National Health Investors Inc

+0.32 (+0.46%)

USD 3.17B
LTC LTC Properties Inc

+0.24 (+0.70%)

USD 1.59B
UHT Universal Health Realty Income..

+0.20 (+0.54%)

USD 0.56B
CHCT Community Healthcare Trust Inc

+0.36 (+2.01%)

USD 0.52B
GMRE-PA Global Medical REIT Inc

+0.39 (+1.56%)

USD 0.40B
OHI Omega Healthcare Investors Inc

+0.26 (+0.69%)

N/A

ETFs Containing CTRE

FCII:CA Franklin ClearBridge Sust.. 5.73 % 0.00 %

+0.09 (+0.41%)

CAD 0.02B
FXU First Trust Utilities Alp.. 3.73 % 0.63 %

+0.24 (+0.41%)

N/A
HDLV 3.31 % 0.00 %

N/A

N/A
XLUY 3.00 % 0.00 %

N/A

N/A
CZA Invesco Zacks Mid-Cap ETF 2.03 % 0.65 %

+0.66 (+0.41%)

N/A
CDL VictoryShares US Large Ca.. 1.50 % 0.35 %

+0.37 (+0.41%)

USD 0.36B
CDC VictoryShares US EQ Incom.. 1.46 % 0.35 %

+0.40 (+0.41%)

USD 0.82B
ULVM VictoryShares US Value Mo.. 1.29 % 0.20 %

+0.55 (+0.41%)

USD 0.15B
XSLV Invesco S&P SmallCap Low .. 1.10 % 0.25 %

+0.33 (+0.41%)

USD 0.31B
DIVA 1.07 % 1.00 %

N/A

N/A
ULOV:LSE 0.72 % 0.00 %

N/A

N/A
DVY iShares Select Dividend E.. 0.00 % 0.39 %

+0.86 (+0.41%)

N/A
FVD First Trust Value Line® .. 0.00 % 0.70 %

+0.30 (+0.41%)

N/A
BLES Inspire Global Hope ETF 0.00 % 0.62 %

+0.31 (+0.41%)

USD 0.11B
EXX5:F iShares Dow Jones U.S. Se.. 0.00 % 0.00 %

N/A

N/A
FTGU:F First Trust Global Funds .. 0.00 % 0.00 %

N/A

N/A
HDLV:F Invesco S&P 500 High Divi.. 0.00 % 0.00 %

N/A

N/A
FTGU:XETRA First Trust US Large Cap .. 0.00 % 0.00 %

N/A

USD 0.10B
HSMV First Trust Horizon Manag.. 0.00 % 0.00 %

+0.26 (+0.41%)

USD 0.02B

Market Performance

  Market Performance vs. Industry/Classification (REIT - Healthcare Facilities) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 22.39% 64% D 79% B-
Dividend Return 5.18% 36% F 68% D+
Total Return 27.57% 64% D 82% B
Trailing 12 Months  
Capital Gain 20.66% 64% D 79% B-
Dividend Return 6.34% 36% F 76% C+
Total Return 27.00% 64% D 83% B
Trailing 5 Years  
Capital Gain 34.73% 92% A 68% D+
Dividend Return 27.87% 62% D 79% B-
Total Return 62.59% 92% A 74% C
Average Annual (5 Year Horizon)  
Capital Gain 10.79% 86% B+ 67% D+
Dividend Return 16.04% 86% B+ 73% C
Total Return 5.25% 50% F 84% B
Risk Return Profile  
Volatility (Standard Deviation) 22.69% 57% F 48% F
Risk Adjusted Return 70.69% 86% B+ 82% B
Market Capitalization 5.50B 70% C- 79% B-

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

Low debt

The company is less leveraged than its peers ,, and is among the top quartile, which makes it more flexible. However, do check the news and look at its sector. Sometimes this is low because the company is not growing and has no growth potential.

Superior return on assets

The company management has delivered better return on assets in the most recent 4 quarters than its peers, placing it in the top quartile.

Superior capital utilization

The company management has delivered better return on invested capital in the most recent 4 quarters than its peers, placing it in the top quartile.

High dividend returns

The stock has outperformed its sector peers on average annual dividend returns basis in the past 5 years (for a hold period of at least 12 months) and is in the top quartile. This can be a good buy, especially if it is outperforming on total return basis , for investors seeking high income yields.

Positive cash flow

The company had positive total cash flow in the most recent four quarters.

Positive free cash flow

The company had positive total free cash flow in the most recent four quarters.

High Gross Profit to Asset Ratio

This stock is in the top quartile compared to its peers on Gross Profit to Asset Ratio. This is a popular measure among value investors for showing superior returns in the long run.

What to not like:
Overpriced on cashflow basis

The stock is trading high compared to its peers on a price to cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Below median total returns

The company has under performed its peers on annual average total returns in the past 5 years.

Overpriced on free cash flow basis

The stock is trading high compared to its peers on a price to free cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Low Dividend Growth

This stock has shown below median dividend growth in the previous 5 years compared to its sector.